341 related articles for article (PubMed ID: 12574580)
1. Acetylcholinesterase inhibitors for vascular dementia and Alzheimer's disease combined with cerebrovascular disease.
Bowler JV
Stroke; 2003 Feb; 34(2):584-6. PubMed ID: 12574580
[No Abstract] [Full Text] [Related]
2. A comparison of donepezil and galantamine in the treatment of cognitive symptoms of Alzheimer's disease: a meta-analysis.
Harry RD; Zakzanis KK
Hum Psychopharmacol; 2005 Apr; 20(3):183-7. PubMed ID: 15700322
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomized trial.
Kertesz A
Curr Neurol Neurosci Rep; 2002 Nov; 2(6):503-4. PubMed ID: 12359103
[No Abstract] [Full Text] [Related]
4. Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomized trial.
Marder K
Curr Neurol Neurosci Rep; 2002 Sep; 2(5):389-90. PubMed ID: 12169216
[No Abstract] [Full Text] [Related]
5. Treatment of vascular dementia-evidence from clinical trials with cholinesterase inhibitors.
Erkinjuntti T; Román G; Gauthier S
Neurol Res; 2004 Jul; 26(5):603-5. PubMed ID: 15265282
[TBL] [Abstract][Full Text] [Related]
6. [The use of galantamine in Alzheimer's disease associated with vascular dementia (according to the study of T. Erkinjuntti group)].
Damulin IV
Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(5):65-7. PubMed ID: 19938276
[No Abstract] [Full Text] [Related]
7. For debate: is the evidence for the efficacy of cholinesterase inhibitors in the symptomatic treatment of Alzheimer's disease convincing or not?
Ames D; Kaduszkiewicz H; van den Bussche H; Zimmermann T; Birks J; Ashby D
Int Psychogeriatr; 2008 Apr; 20(2):259-92. PubMed ID: 18252031
[No Abstract] [Full Text] [Related]
8. Comparative analysis of mortality in patients with Alzheimer's disease treated with donepezil and galantamine.
Capellà D; Vidal X
Age Ageing; 2007 Mar; 36(2):234; author reply 235. PubMed ID: 17255086
[No Abstract] [Full Text] [Related]
9. [Medical treatment of Alzheimer's disease].
Johannsen P
Ugeskr Laeger; 2006 Oct; 168(40):3424-9. PubMed ID: 17032609
[TBL] [Abstract][Full Text] [Related]
10. Cognitive decline and treatment options for patients with vascular dementia.
Erkinjuntti T
Acta Neurol Scand Suppl; 2002; 178():15-8. PubMed ID: 12492787
[TBL] [Abstract][Full Text] [Related]
11. The effect of donepezil treatment on cardiovascular mortality.
Sato K; Urbano R; Yu C; Yamasaki F; Sato T; Jordan J; Robertson D; Diedrich A
Clin Pharmacol Ther; 2010 Sep; 88(3):335-8. PubMed ID: 20664535
[TBL] [Abstract][Full Text] [Related]
12. Galantamine for vascular cognitive impairment.
Birks J; Craig D
Cochrane Database Syst Rev; 2006 Jan; (4):CD004746. PubMed ID: 23862185
[TBL] [Abstract][Full Text] [Related]
13. Treatment of vascular dementia--evidence from clinical trials with cholinesterase inhibitors.
Erkinjuntti T; Román G; Gauthier S
J Neurol Sci; 2004 Nov; 226(1-2):63-6. PubMed ID: 15537522
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomised trial.
Erkinjuntti T; Kurz A; Gauthier S; Bullock R; Lilienfeld S; Damaraju CV
Lancet; 2002 Apr; 359(9314):1283-90. PubMed ID: 11965273
[TBL] [Abstract][Full Text] [Related]
15. The long-term efficacy and tolerability of donepezil in patients with vascular dementia.
Wilkinson D; Róman G; Salloway S; Hecker J; Boundy K; Kumar D; Posner H; Schindler R
Int J Geriatr Psychiatry; 2010 Mar; 25(3):305-13. PubMed ID: 19623601
[TBL] [Abstract][Full Text] [Related]
16. AD2000: donepezil in Alzheimer's disease.
Schneider LS
Lancet; 2004 Jun; 363(9427):2100-1. PubMed ID: 15220027
[No Abstract] [Full Text] [Related]
17. Galantamine for vascular cognitive impairment.
Craig D; Birks J
Cochrane Database Syst Rev; 2006 Jan; 2006(1):CD004746. PubMed ID: 16437493
[TBL] [Abstract][Full Text] [Related]
18. [Donepezil in Alzheimer's disease and vascular dementia].
Damulin IV
Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(7):71-5. PubMed ID: 24073452
[No Abstract] [Full Text] [Related]
19. Cholinesterase inhibitors in the clinical management of Alzheimer's disease: importance of early and persistent treatment.
Seltzer B
J Int Med Res; 2006; 34(4):339-47. PubMed ID: 16989488
[TBL] [Abstract][Full Text] [Related]
20. Are cholinesterase inhibitors effective in the management of the behavioral and psychological symptoms of dementia in Alzheimer's disease? A systematic review of randomized, placebo-controlled trials of donepezil, rivastigmine and galantamine.
Rodda J; Morgan S; Walker Z
Int Psychogeriatr; 2009 Oct; 21(5):813-24. PubMed ID: 19538824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
